Edition:
United Kingdom

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

3.54USD
22 Jan 2018
Change (% chg)

-- (--)
Prev Close
$3.54
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,738
52-wk High
$5.10
52-wk Low
$2.82

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.03 -0.086
Jun '17 0.01 -0.052
Mar '17 0.08 -0.057
FY 2016 Dec '16 0.04 -0.059
Sep '16 0.05 -0.067
Jun '16 0.15 -0.084
Mar '16 0.04 -0.076
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.70 32.91
P/E High - Last 5 Yrs. -- 302.09 46.01
P/E Low - Last 5 Yrs. -- 94.18 24.39
Beta 0.85 0.88 0.89
Price to Sales (TTM) 1,110.25 94.43 5.45
Price to Book (MRQ) -- 13.36 5.40
Price to Tangible Book (MRQ) -- 13.64 6.91
Price to Cash Flow (TTM) -- 72.87 23.44
% Owned Institutions 5.90 11.52 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.72 5.21
Payout Ratio(TTM) -- 16.22 43.69

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -93.70 401.22 9.10
Sales (TTM) vs TTM 1 Yr. Ago -42.39 71.05 5.46
Sales - 5 Yr. Growth Rate -38.07 33.10 10.29
EPS (MRQ) vs Qtr. 1 Yr. Ago 37.65 29.49 19.71
EPS (TTM) vs TTM 1 Yr. Ago 55.50 -- --
EPS - 5 Yr. Growth Rate -- 40.21 10.75
Capital Spending - 5 Yr. Growth Rate -39.54 40.33 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.94 1.77 2.18
Current Ratio (MRQ) 0.94 5.23 2.98
LT Debt to Equity (MRQ) -- 21.05 12.13
Total Debt to Equity (MRQ) -- 22.61 16.42
Interest Coverage (TTM) -88.90 -102.06 33.18

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 15.24 41.21 54.71
Gross Margin - 5 Yr. Avg. 89.96 52.54 52.40
EBITD Margin (TTM) -6,209.52 -- --
EBITD - 5 Yr. Avg -383.86 -239.51 15.28
Operating Margin (TTM) -6,210.97 -519.41 7.56
Operating Margin - 5 Yr. Avg. -384.15 -256.70 10.75
Pre-Tax Margin (TTM) -6,370.48 -494.96 8.34
Pre-Tax Margin - 5 Yr. Avg. -387.78 -256.63 11.15
Net Profit Margin (TTM) -6,370.48 -496.46 4.66
Net Profit Margin - 5 Yr. Avg. -387.36 -259.85 7.45
Effective Tax Rate (TTM) -- 23.29 23.07
Effective Tax Rate - 5 Yr. Avg. -- 18.77 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 45,045 23,318,311 858,000,222
Net Income/Employee (TTM) -2,869,585 3,079,098 100,930,107
Receivable Turnover (TTM) 12.23 20.24 5.77
Inventory Turnover (TTM) 8.87 2.31 3.35
Asset Turnover (TTM) 0.21 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -1,329.05 0.09 11.00
Return on Assets - 5 Yr. Avg. -530.60 0.51 12.38
Return on Investment (TTM) -- 3.19 14.44
Return on Investment - 5 Yr. Avg. -- 3.64 16.19
Return on Equity (TTM) -- 4.52 16.13
Return on Equity - 5 Yr. Avg. -- 8.98 17.53
  1 Year 3 Year 5 Year
Sales % -89.73 -56.13 -38.07
EPS (TTM) % 40.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nymox Pharmaceutical Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.03%
# of Holders: 72
Total Shares Held: 3,308,428
3 Mo. Net Change: 62,816
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 8
# Reduced Positions: 2
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.